Summary:
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
Qualified Participants Must:
• Be adult patients, aged 18 years and above
•
Have a clinical diagnosis of schizophrenia with a minimum duration of 1 year
Qualified Participants May Receive:
$75.00 per every completed visit